Lymphoma

This article discusses findings from a clinical trial showing that Keytruda prolongs the time without disease progression in patients with relapsed or refractory classical Hodgkin lymphoma compared with the current standard of therapy. Read More ›

A year before Lynden was diagnosed with cancer, she cut off her hair and donated it to help kids with cancer. After her diagnosis, she launched a new project. She is just getting started, but so far she has raised more than $65,000 for pediatric cancer research. Read More ›

Rex Jones found a unique way to keep his mood upbeat and spread good vibes to others during his chemotherapy for lymphoma. Read More ›

Stacey Roselle looked for the “silver linings” when a diagnosis of non-Hodgkin lymphoma brought her face-to-face with unexpected reactions to her illness. Read More ›

When 24-year-old Mia Brister was diagnosed with Hodgkin lymphoma, it was as if her whole world had shattered. She had to learn to be kind with herself to put her life together again. Read More ›

In November 2019, the FDA approved the second Bruton tyrosine kinase inhibitor for the treatment of adults with mantle-cell lymphoma (a type of non-Hodgkin lymphoma) who have received at least 1 previous therapy. Read More ›

People who are diagnosed with blood cancer need to learn enough about it without being overwhelmed, and to take part in their treatment decisions. Communicate important personal information to your care team. Read More ›

In June 2019, the FDA approved a new type of immunotherapy called Polivy, for use in combination with other drugs, in patients with previously treated diffuse large B-cell lymphoma (DLBCL), offering new options for patients whose cancer has returned. Read More ›

Read More ›

Brigid Wallace contemplates the choices she made when living in the “new normal” after her cancer diagnosis. She describes the struggles and personal victories that tested her faith and strength after she learned she had non-Hodgkin lymphoma. Read More ›